Trial Profile
Comparison of efficacy of Diphereline and Variopeptyl in treatment of girls with idiopathic central precocious puberty
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Precocious puberty
- Focus Therapeutic Use
- 18 Jun 2018 New trial record